Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1

Han, LJ; Li, YL; Wu, JY; Peng, J; Han, XL; Zhao, HM; He, C; Li, YY; Wang, WM; Zhang, MM; Li, YF; Sun, H; Cao, HX; Sang, LN; Jiang, ZX; Yu, JF

Han, LJ; Yu, JF (通讯作者)，Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Peoples R China.

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022; 116 (6): 892

Abstract

Objectives This study retrospectively investigated in which cycle measurable residual disease (MRD) is associated with prognosis in patients in first ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索